Arlene Joyner is a branch chief at the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services and the deputy director of the Pharmaceutical Countermeasure Infrastructure Division that leads several mission critical program activities focusing on public private partnerships. Within BARDA, she is also the program manager for Fill Finish Manufacturing (FFMN) and Contract Development and Manufacturing Organization (CDMO) Networks that oversee essential BARDA Core Service programs. Arlene is also the continuous manufacturing program lead and is the technical monitor for all contractor staff that specialize in small molecules, large molecules and vaccines, technology transfers, manufacturing and product development, analytical methods, IP issues, and supply chain and logistics. Most recently she led efforts to ensure Fill Finish manufacturing capacity availability for the vaccines and therapeutics supported by the USG as part of the Operation Warp Speed Federal COVID19 Response.
Before joining BARDA, she spent six years at Merck & Co. conducting quality auditing and supervising vaccine manufacturing operations. She also worked at Baxter in the vaccines division for 16 years where her responsibilities included upstream manufacturing/fermentation, downstream/purification manufacturing, column chromatography, buffer preparation, supply chain and program management operations. Ms. Joyner received her BS in Chemical Engineering from Penn State and her MS in Chemical Engineering from Villanova University.